WithdrawnNot Applicable

A Pilot Study to Explore the Role of Gut Flora in Psoriasis

Stopped: Company focus shifted

United States0Started 2020-03-02

Plain-language summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Psoriasis.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Signed informed consent by patient
✓. Male or female patients age 18 and older.
✓. Diagnosis of Psoriasis based on PSAI of greater than or equal to 12 at screening

✕. Refusal by patient to sign informed consent form
✕. Treatment with antibiotics within 2 weeks prior to screening
✕. Treatment with probiotics within 6 weeks prior to screening
✕. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
✕. Postoperative stoma, ostomy, or ileoanal pouch
✕. Participation in any experimental drug protocol within the past 12 weeks
✕. Treatment with total parenteral nutrition
✕. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial

Correlation of Microbiome to Psoriasis via Relative Abundance Found in Microbiome Sequencing

Timeframe: 1 year

NCT IDNCT04099979

SponsorProgenaBiome

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-03